Physician profile
Corey Rosenbaum
NPI 1740414317
$43,327.16
in general payments reported to CMS, 2019-2025
31 companies · $17K in 2025
The $17K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,989 · 2020: $215 · 2021: $2,686 · 2022: $2,111 · 2023: $13K · 2024: $5,759 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $21K · Food and Beverage: $7,624 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $21,451.18 |
| Food and Beverage | $7,624.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team 1, LLC | $17,122.43 | 2021-2025 | |
| Arthrex, INC. | $9,577.15 | 2021-2025 | Arthrex |
| Stryker Corporation | $8,745.21 | 2019-2025 | Prostep, Pangea, Pro |
| Wright Medical Technology, INC. | $2,849.28 | 2019-2020 | |
| Medical Device Business Services, INC. | $1,694.17 | 2025 | Motoband |
| Depuy Synthes Sales INC. | $1,183.22 | 2019-2025 | Na, N/A, Motoband |
| Paragon 28, INC. | $425.39 | 2023 | Portfolio, Apex 3d, Gorilla |
| Medline Industries Lp | $403.50 | 2022-2025 | |
| International Life Sciences | $336.80 | 2023 | |
| Treace Medical Concepts, INC. | $192.69 | 2022 | |
| Exactech, INC. | $154.11 | 2023 | |
| Accufix Surgical INC. | $118.01 | 2025 | Accu-Joint |
| Ebi, LLC | $59.93 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Dynasplint Systems INC. | $50.58 | 2021 | |
| Pacira Therapeutics, INC. | $46.16 | 2020-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $40.02 | 2019 | |
| Djo, LLC | $38.32 | 2020-2021 | |
| Boston Scientific Corporation | $33.63 | 2025 | General - Pain Management |
| Kci USA, INC. | $31.91 | 2020-2023 | Activ.A.C., Prevena |
| Zimmer Biomet Holdings, INC. | $25.11 | 2025 | Tapestry |
| Heron Therapeutics, INC. | $24.26 | 2021 | |
| Axogen | $22.87 | 2022 | |
| Orthofix Medical, INC. | $22.41 | 2023-2025 | Physio-Stim |
| Linvatec Corporation | $20.88 | 2024 | Allograft Tissue, Biobrace 23mm |
| Embody, INC. | $19.08 | 2022 | |
| Kerecis Limited | $18.75 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $17.74 | 2024 | Restrata Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $16.80 | 2022 | |
| Zimvie INC. | $15.24 | 2023 | |
| Sanara Medtech INC. | $14.56 | 2023 | Celleraterx |
| Biocomposites INC | $6.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Rosenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.